Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Visualizzazioni
• 08/09/23
0
0
Incorporare
administrator
Iscritti
Dr. Prince, Professor, The University of Melbourne and Monash University, talks about the outcomes of the ALCANZA study in CD30-expressing CTCL
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti